Evidence map›Paper›PMID 21502813›Full record

ArticleCell cycle (Georgetown, Tex.)2011

Aquaglyceroporins serve as metabolic gateways in adiposity and insulin resistance control.

Amaia Rodríguez, Victoria Catalán, Javier Gómez-Ambrosi, Gema Frühbeck

Open access · bronzeAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 134 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Morphological and Molecular Investigations of Aquaporin-7 (AQP-7) in MaleAnimals : an open access journal from MDPI · 2023
    Article
  14. Review
  15. Aquaporins in Tumor.Advances in experimental medicine and biology · 2023
    Article
  16. Transport Characteristics of Aquaporins.Advances in experimental medicine and biology · 2023
    Article
  17. Article
  18. Article
  19. Review
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Amaia RodríguezClínica Universidad de Navarra, Pamplona, Spain. arodmur@unav.es
Victoria Catalán
Javier Gómez-Ambrosi
Gema Frühbeck
Clinica Universidad de Navarra · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aquaglyceroporins (AQP3, AQP7, AQP9 and AQP10) encompass a subfamily of aquaporins that allow the movement of water and other small solutes, especially glycerol, through cell membranes. Adipose tissue constitutes a major source of glycerol via AQP7. We have recently reported that, in addition to the well-known expression of AQP7 in adipose tissue, AQP3 and AQP9 are also expressed in omental and subcutaneous fat depots. Moreover, insulin and leptin act as regulators of aquaglyceroporins through the PI3K/Akt/mTOR pathway. AQP3 and AQP7 appear to facilitate glycerol efflux from adipose tissue while reducing the glycerol influx into hepatocytes via AQP9 to prevent the excessive lipid accumulation and the subsequent aggravation of hyperglycemia in human obesity. This Extra View focuses on the control of glycerol release by aquaglyceroporins in the adipose tissue and briefly discusses the importance of glycerol as a substrate for hepatic gluconeogenesis, pancreatic insulin secretion and cardiac ATP production.

Indexed as

AdiposityInsulin ResistanceAdenosine TriphosphateAdipose TissueAquaglyceroporinsAquaporin 3AquaporinsGluconeogenesisGlycerolHumansInsulinInsulin-Secreting CellsLipogenesisLipolysisLiverAdenosine TriphosphateAQP3 protein, humanAQP7 protein, humanAQP9 protein, humanAquaglyceroporinsAquaporin 3AquaporinsGlycerolInsulin

Identifiers

PMID21502813
PMCPMC3127157
OpenAlexW2015383616

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.